Literature DB >> 33683002

Congenital polyvalvular disease expands the cardiac phenotype of the RASopathies.

Dena R Matalon1, David A Stevenson1, Elizabeth J Bhoj2, Avni B Santani2, Beth Keena2, Meryl S Cohen3, Angela E Lin4, Sarah E Sheppard2, Elaine H Zackai2.   

Abstract

The RASopathies are a group of similar genetic syndromes with cardiovascular abnormalities, characteristic facial features, short stature, abnormalities of the skin and musculoskeletal system, and variable neurodevelopmental challenges. The most common cardiovascular abnormalities include pulmonary valvular stenosis and hypertrophic cardiomyopathy. Congenital polyvalvular disease (CPVD) refers to congenital dysplasia of two or more cardiac valves. We diagnosed a RASopathy in two individuals with CPVD and noted that CPVD in RASopathies has rarely been reported in the literature. Thus, we performed a retrospective chart review and literature review to investigate the association and characterize the phenotype of CPVD in the RASopathies. CPVD was present in 2.5% (n = 6/243) of individuals in our RASopathy cohort. Involvement of two cardiac valves, commonly the aortic and pulmonic valves, was seen in the majority of individuals (6/8; 75%) in our cohort, but only 27% (3/11) of reported CPVD and RASopathy cases in the literature. CPVD should be considered an associated cardiovascular phenotype of the RASopathies, which has implications for diagnosis and management.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Noonan syndrome; PTPN11; RASopathies; cardiofaciocutaneous (CFC) syndrome; connective tissue disease; polyvalvular disease

Mesh:

Substances:

Year:  2021        PMID: 33683002      PMCID: PMC8711298          DOI: 10.1002/ajmg.a.62146

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  29 in total

1.  Myhre syndrome: Clinical features and restrictive cardiopulmonary complications.

Authors:  Lois J Starr; Dorothy K Grange; Jeffrey W Delaney; Anji T Yetman; James M Hammel; Jennifer N Sanmann; Deborah A Perry; G Bradley Schaefer; Ann Haskins Olney
Journal:  Am J Med Genet A       Date:  2015-09-30       Impact factor: 2.802

2.  Atypical cardiac defects in patients with RASopathies: Updated data on CARNET study.

Authors:  Giulio Calcagni; Giulia Gagliostro; Giuseppe Limongelli; Marta Unolt; Enrica De Luca; Maria C Digilio; Anwar Baban; Sonia B Albanese; Giovanni B Ferrero; Giuseppina Baldassarre; Gabriella Agnoletti; Elena Banaudi; Jan Marek; Juan P Kaski; Giulia Tuo; Maurizio Marasini; Francesca Cairello; Andrea Madrigali; Giuseppe Pacileo; Maria G Russo; Ornella Milanesi; Roberto Formigari; Maurizio Brighenti; Luca Ragni; Andrea Donti; Fabrizio Drago; Bruno Dallapiccola; Marco Tartaglia; Bruno Marino; Paolo Versacci
Journal:  Birth Defects Res       Date:  2020-06       Impact factor: 2.344

Review 3.  Familial cardiac valvulopathy due to filamin A mutation.

Authors:  Jonathan A Bernstein; Daniel Bernstein; Ute Hehr; Louanne Hudgins
Journal:  Am J Med Genet A       Date:  2011-08-03       Impact factor: 2.802

4.  Cervical artery dissection expands the cardiovascular phenotype in FBN1-related Weill-Marchesani syndrome.

Authors:  Kelsey Newell; Wendy Smith; Brian Ghoshhajra; Eric Isselbacher; Angela Lin; Mark E Lindsay
Journal:  Am J Med Genet A       Date:  2017-07-11       Impact factor: 2.802

5.  Geleophysic dysplasia: 48 year clinical update with emphasis on cardiac care.

Authors:  Janet M Legare; Peggy Modaff; Samuel P Strom; Richard M Pauli; Heather L Bartlett
Journal:  Am J Med Genet A       Date:  2018-09-08       Impact factor: 2.802

6.  Geleophysic dysplasia.

Authors:  J Spranger; E F Gilbert; S Arya; G M Hoganson; J M Opitz
Journal:  Am J Med Genet       Date:  1984-11

7.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

Review 8.  Congenital polyvalvular disease: a review.

Authors:  U Bartram; M M Bartelings; H H Kramer; A C Gittenberger-de Groot
Journal:  Pediatr Cardiol       Date:  2001 Mar-Apr       Impact factor: 1.655

9.  Congenital heart anomalies in the trisomy 18 syndrome, with reference to congenital polyvalvular disease.

Authors:  R Matsuoka; K Misugi; A Goto; E F Gilbert; M Ando
Journal:  Am J Med Genet       Date:  1983-04

10.  Echocardiographic evaluation of the spectrum of cardiac anomalies associated with trisomy 13 and trisomy 18.

Authors:  N N Musewe; D J Alexander; I Teshima; J F Smallhorn; R M Freedom
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.